It is not possible to make a general recommendation about their use but they can be considered in individual cases (Table 6)
doi: 10.1056/NEJMoa1911303
(PubMed) That doesnt automatically translate to healthier, and it certainly doesnt translate to safe to combine with other secretagogues indefinitely. A clinician-friendly framework to evaluate any peptide stack you see online If you want the full decision logic, use Metos pillar: Heres the condensed version Id use in a consult: Step 1: Define the outcome in one sentence Not fat loss. Instead: Reduce visceral adiposity and improve triglycerides in 12 weeks, or Improve return-to-running tolerance after a tendon injury. Step 2: Grade evidence, not enthusiasm Use three buckets: A: Human outcomes evidence (best) B: Human biomarker evidence (useful but indirect) C: Preclinical/mechanistic only (hypothesis) Example: Semaglutide for weight loss: A CJC-1295 for raising IGF-1: B BPC-157/TB-500 for tendon healing: often C low B , depending on claim Step 3: Avoid redundancy If two compounds push the same pathway, youre more likely to get side effects than synergy

With Mounjaro, many people experience effective weight loss at lower doses
But the moment you stop taking it, everything goes back to the way it was, she said
Individuals with malabsorption issues or those taking certain medications may not benefit from oral B12 at all, making Vitamin B12 injections in Miami the gold standard for restoring balance